ORIGINAL RESEARCH article
Front. Nutr.
Sec. Nutrition and Microbes
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1597390
This article is part of the Research TopicXenobiotics, Gut Microbiota, and Chronic DiseaseView all 9 articles
Gut Microbiota and Protein-to-Protein Ratios in NAFLD: Insights from Mendelian Randomization and Murine Studies
Provisionally accepted
- People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Gut microbiota and protein metabolism play critical roles in non-alcoholic fatty liver disease (NAFLD) progression, but their causal relationships remain unclear. This study integrates mendelian randomization (MR) analysis and experimental validation to identify microbial and molecular contributors to NAFLD and explore potential therapeutic targets.Methods: Two-sample MR analysis was performed to assess the causal effects of gut microbiota and protein-to-protein ratios on NAFLD using inverse variance-weighted, maximum likelihood, MR-Egger, weighted median, weighted mode, and Wald ratio methods. Sensitivity analyses were conducted to ensure result robustness. Mediation analysis was applied to examine whether protein-to-protein ratios mediate the link between gut microbiota and NAFLD.Results: MR analysis identified 19 gut microbial taxa and 148 protein-to-protein ratios significantly associated with NAFLD. Additionally, 49 significant mediation relationships were identified, where 7 gut microbial taxa influenced NAFLD via 45 protein-to-protein ratios. MR analysis identified 38 proteins significantly associated with NAFLD, derived from 192 unique proteins involved in 148 NAFLD-related protein-to-protein ratios. Experimental validation confirmed the protective role of Lactobacillus salivarius, which alleviated hepatic lipid accumulation, improved glucose-lipid metabolism, and reduced inflammatory cytokine expression. Among the identified targets, the hepatic mRNA expression levels of ANGPT1, SKAP2, SPARC, and STAMBP were significantly upregulated in NAFLD tissues and were markedly reduced following Lactobacillus salivarius supplementation.This study establishes a causal link between gut microbiota, protein metabolism, and NAFLD, identifying microbial and molecular targets for intervention.The findings support microbiota-based therapies and protein biomarkers for NAFLD management, warranting further clinical validation.
Keywords: Gut Microbiota, protein-to-protein ratios, NAFLD, Mendelian randomization, Lactobacillus salivarius
Received: 21 Mar 2025; Accepted: 30 Jun 2025.
Copyright: © 2025 Lei, Shi, Yang, Lin, Liang, Huang, Pan and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Wei Li, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.